Sun Pharmaceutical Industries Ltd.
BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1760.85
17.85 (1.02%) Sun Pharmaceutical Industries informs about press release
Date: 15-07-2026Sun Pharmaceutical Industries has informed that it enclosed a copy of the press release titled ‘Sun Pharma receives approval to manufacture and market generic semaglutide in South Africa,’ which shall be released after this intimation.
The above information is a part of company’s filings submitted to BSE.